from the United States Court of Appeals for the Third Circuit
See other cases from the Third Circuit.
Rescheduled.
Reply of petitioners AstraZeneca Pharmaceuticals LP, et al. filed. (Distributed)
Waiver of the 14-day waiting period for the distribution of the petition pursuant to Rule 15.5 filed by petitioner.
Brief of respondents Secretary of Health and Human Services, Robert F. Kennedy, et al. in opposition filed.
Motion to extend the time to file a response is granted and the time is further extended to and including January 2, 2026.
Motion to extend the time to file a response from December 24, 2025 to January 2, 2026, submitted to The Clerk.
Motion to extend the time to file a response is granted and the time is further extended to and including December 24, 2025.
Motion to extend the time to file a response from November 24, 2025 to December 24, 2025, submitted to The Clerk.
Motion to extend the time to file a response is granted and the time is extended to and including November 24, 2025.
Motion to extend the time to file a response from October 24, 2025 to November 24, 2025, submitted to The Clerk.
Petition for a writ of certiorari filed. (Response due October 24, 2025)
Application (25A115) granted by Justice Alito extending the time to file until September 20, 2025.
Application (25A115) to extend the time to file a petition for a writ of certiorari from August 6, 2025 to September 20, 2025, submitted to Justice Alito.
AstraZeneca Pharmaceuticals LP, et al., Petitioner, represented by Allon Kedem
Secretary of Health and Human Services, Robert F. Kennedy,, et al., Respondent, represented by D. John Sauer